Comparison Interventions on Kinetic and Kinematic Parameters (Balance)

January 3, 2026 updated by: Medical University of Gdansk

Comparison of Selected Physiotherapeutic Interventions on Kinetic and Kinematic Parameters in Young Soccer Players

Currently, it is difficult to find studies in the literature comparing proprioception exercises with the effect of manual therapy on improving balance, and in the long run it may translate into improved activity, functionality and injury prevention in athletes, when planning training or therapy, e.g. in patients after ankle sprains.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Enrolling by invitation

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Interventional

Enrollment (Estimated)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
45

Phase

Phase

The stage of a clinical trial studying a drug or biological product, based on definitions developed by the U.S. Food and Drug Administration (FDA). The phase is based on the study's objective, the number of participants, and other characteristics. There are five phases: Early Phase 1 (formerly listed as Phase 0), Phase 1, Phase 2, Phase 3, and Phase 4. Not Applicable is used to describe trials without FDA-defined phases, including trials of devices or behavioral interventions.
  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Poland
      • Gdansk, Poland, 80-210
        • Escola Futbolu Pruszcz Gdański

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Age 11-13 years
  • Male
  • Minimum 2 years of experience in soccer coaching
  • Participation in regular club training (at least 3 times a week)
  • Parental/legal guardian consent and participant consent to participate in the study
  • No medical contraindications to physical activity

Exclusion Criteria:

  • Current injury or contusion of the musculoskeletal system that prevents full participation in training
  • Chronic diseases that may affect the musculoskeletal system or balance
  • Participation in other training programs focused on proprioception or undergoing other physiotherapy interventions during the study period

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm

Participant Group / Arm

A group or subgroup of participants in a clinical trial that receives a specific intervention/treatment, or no intervention, according to the trial's protocol.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Experimental: Group A "Diagonal Mobilization'
Will be used: manipulation, placebo and exercise
Other: Manual therapy
This technique involves mobilizing the upper ankle joints by mobilizing the talus and calcaneus, improving pronation.
Other: Placebo
The players will perform their own type of pro-receptive training.
Other: Exercise
Pro-receptive training will be performed.
Placebo Comparator: Group B "Placebo"
Will be used: manipulation, placebo and exercise
Other: Manual therapy
This technique involves mobilizing the upper ankle joints by mobilizing the talus and calcaneus, improving pronation.
Other: Placebo
The players will perform their own type of pro-receptive training.
Other: Exercise
Pro-receptive training will be performed.
Active Comparator: Group C "Proprioception Training"
Will be used: manipulation, placebo and exercise
Other: Manual therapy
This technique involves mobilizing the upper ankle joints by mobilizing the talus and calcaneus, improving pronation.
Other: Placebo
The players will perform their own type of pro-receptive training.
Other: Exercise
Pro-receptive training will be performed.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Y balance test
Time Frame: The test will be administered twice during a single training session. Baseline (0 minutes before the intervention) and immediately post-intervention (within 5 minutes after completion of the training session). Each test will be repeated three times.
Consists of the volunteer standing on one leg while simultaneously stretching the other lower limb in 3 different directions. These are: anterior, posteromedial and posterolateral.
The test will be administered twice during a single training session. Baseline (0 minutes before the intervention) and immediately post-intervention (within 5 minutes after completion of the training session). Each test will be repeated three times.
1. Balance
Time Frame: The test will be administered twice during a single training session. Baseline (0 minutes before the intervention) and immediately post-intervention (within 5 minutes after completion of the training session). Each test will be repeated three times.
K-FORCE plates assess balance characteristics during testing.
The test will be administered twice during a single training session. Baseline (0 minutes before the intervention) and immediately post-intervention (within 5 minutes after completion of the training session). Each test will be repeated three times.

Secondary Outcome Measures

Secondary Outcome Measures

In a clinical study's protocol, a planned outcome measure that is not as important as the primary outcome measure for evaluating the effect of an intervention but is still of interest. Most clinical studies have more than one secondary outcome measure.
Outcome Measure
Measure Description
Time Frame
Assessment of proprioception.
Time Frame: The test will be administered twice during a single training session. Baseline (0 minutes before the intervention) and immediately post-intervention (within 5 minutes after completion of the training session). Each test will be repeated three times.
The proprioception assessment involves assessing the angular position of the joint and then attempting to reproduce it, measured in degrees. The assessment will be conducted at 30 degrees, 60 degrees, and 90 degrees.
The test will be administered twice during a single training session. Baseline (0 minutes before the intervention) and immediately post-intervention (within 5 minutes after completion of the training session). Each test will be repeated three times.
Muscle strength assessment
Time Frame: The test will be administered twice during a single training session. Baseline (0 minutes before the intervention) and immediately post-intervention (within 5 minutes after completion of the training session). Each test will be repeated three times.
The K-FORCE Push Test allows you to assess your strength characteristics during the hip abduction test.
The test will be administered twice during a single training session. Baseline (0 minutes before the intervention) and immediately post-intervention (within 5 minutes after completion of the training session). Each test will be repeated three times.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Medical University of Gdansk

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
November 20, 2025

Primary Completion (Estimated)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
December 30, 2025

Study Completion (Estimated)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
January 20, 2026

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
November 25, 2025

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 3, 2026

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
January 8, 2026

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
January 8, 2026

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
January 3, 2026

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
November 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • KB/523/2025

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Young Football Players

Clinical Trials on Manual therapy

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings